Development and Validation of an RP-HPLC Method for Determination of Valganciclovir in Human Serum and Tablets
- 12 June 2007
- journal article
- Published by Springer Nature in Chromatographia
- Vol. 66 (S1) , 97-101
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Determination of Abacavir, Lamivudine and Zidovudine in Pharmaceutical Tablets, Human Serum and in Drug Dissolution Studies by HPLCChromatographia, 2007
- ValganciclovirTransplantation Reviews, 2006
- Simultaneous LC determination of trimethoprim and sulphamethoxazole in pharmaceutical formulationsJournal of Pharmaceutical and Biomedical Analysis, 2002
- Pharmacokinetics of valganciclovir and ganciclovir in renal impairmentClinical Pharmacology & Therapeutics, 2002
- Determination of lamivudine and zidovudine in binary mixtures using first derivative spectrophotometric, first derivative of the ratio-spectra and high-performance liquid chromatography–UV methodsAnalytica Chimica Acta, 2002
- RAPID HPLC ASSAY FOR LAMIVUDINE IN PHARMACEUTICALS AND HUMAN SERUMJournal of Liquid Chromatography & Related Technologies, 2002
- QUALITY CONTROL AND DRUG DISSOLUTION STUDIES OF PHARMACEUTICAL PREPARATIONS CONTAINING CERIVASTATIN SODIUM BY MEANS OF RP-HPLC*Journal of Liquid Chromatography & Related Technologies, 2002
- Infections in solid-organ transplant recipientsClinical Microbiology Reviews, 1997
- GanciclovirNew England Journal of Medicine, 1996